Work

Abstract A020: Engineering developability of anti-CD3 scFv-based multispecific T-cell engagers

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.d32026-a020

Authors: Robert Pejchal, Kevin Schutz, Michael Battles, John Bukowski, Olivia Scheideler, Allie LeMay

Institution: Adimab (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7169844535

Cites:

Cited by:

Related to: 10